The prognostic value of CINSARC in a randomised trial comparing histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001).

被引：0
|
作者：
Pasquali, Sandro
Braglia, Luca
Chibon, Frederic
Coindre, Jean Michel
Italiano, Antoine
Romagosa, Cleofe
Bague, Silvia
Dei Tos, Angelo Paolo
Palmerini, Emanuela
Quagliuolo, Vittorio
Broto, Javier Martin
Lopez-Pousa, Antonio
Grignani, Giovanni
Brunello, Antonella
Blay, Jean-Yves
Beveridge, Robert Diaz
Stacchiotti, Silvia
Merlo, Domenico F.
Casali, Paolo Giovanni
Gronchi, Alessandro
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Milan, Italy
[2] IRCCS Azienda Osped Univ San Martino, Ist Ist Nazl Ric Sul Canc, Clin Trial Ctr, Genoa, Italy
[3] IRCCS Azienda Osped Univ San Martino, Ist Ist Nazl Ric Sul Canc, Dept Epidemiol, Genoa, Italy
[4] Inst Bergonie, Bordeaux, France
[5] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
[6] H Vall dHebron, Barcelona, Spain
[7] Hosp St Pau & Santa Creu, Pathol Dept, Barcelona, Spain
[8] Padua Univ Hosp, Padua, Italy
[9] IRCCS Ist Ortoped Rizzoli, Bologna, Italy
[10] Ist Clin Humanitas, Milan, Italy
[11] Univ Seville, Inst Biomed Res IBIS, CSIC, Virgen del Rocio Univ Hosp, Seville, Spain
[12] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[13] IRCCS, FPO, Candiolo Canc Inst, Div Med Oncol, Candiolo, TO, Italy
[14] Ist Oncol Veneto IOV IRCCS, Dept Oncol, Med Oncol Unit 1, Padua, Italy
[15] Ctr Leon Berard, Unicanc, Lyon, France
[16] Med Oncol Dept, Valencia, Spain
[17] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[18] Fdn IRCCS Ist Nazl Tumori, Dept Canc Med, Adult Mesenchymal & Rare Tumor Unit, Milan, Italy
[19] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Sarcoma Serv, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23531
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic role of % changes in longest tumor diameter (LTD) in localized high-risk soft tissue sarcoma (STS) treated with neoadjuvant chemotherapy in a randomized clinical trial.
    Stacchiotti, Silvia
    Morosi, Carlo
    Braglia, Luca
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Lopez-Pousa, Antonio
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Tendero, Oscar
    Beveridge, Robert Diaz
    Lugowska, Iwona
    Fontana, Valeria
    Marchesi, Emanuela
    Palassini, Elena
    Bruzzi, Paolo
    Merlo, Franco Domenico
    Casali, Paolo Giovanni
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
    Pasquali, Sandro
    Vallacchi, Viviana
    Lalli, Luca
    Collini, Paola
    Barisella, Marta
    Romagosa, Cleofe
    Bague, Silvia
    Coindre, Jean Michel
    Dei Tos, Angelo Paolo
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Martin-Broto, Javier
    Lopez-Pousa, Antonio
    Grignani, Giovanni
    Blay, Jean-Yves
    Beveridge, Robert Diaz
    Casiraghi, Elena
    Brich, Silvia
    Renne, Salvatore Lorenzo
    Bergamaschi, Laura
    Vergani, Barbara
    Sbaraglia, Marta
    Casali, Paolo Giovanni
    Rivoltini, Licia
    Stacchiotti, Silvia
    Gronchi, Alessandro
    EBIOMEDICINE, 2024, 106
  • [23] Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
    Issels, RD
    Abdel-Rahman, S
    Wendtner, CM
    Falk, MH
    Kurze, V
    Sauer, H
    Aydemir, U
    Hiddemann, W
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1599 - 1608
  • [24] Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia
    Wendtner, CM
    Abdel-Rahman, S
    Baumert, J
    Falk, MH
    Krych, M
    Santl, M
    Hiddemann, W
    Issels, RD
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1609 - 1616
  • [25] Initial response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) In high-risk soft tissue sarcomas (HR-STS) of adults and its correlation to survival parameters
    Issels, RD
    Abdel-Rahman, S
    Falk, MH
    Salat, C
    Ochmann, O
    Reiser, M
    Hiddemann, W
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S266 - S266
  • [26] Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant+2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.
    Stacchiotti, Silvia
    Pizzamiglio, Sara
    Messina, Antonella
    Morosi, Carlo
    Collini, Paola
    Llombart-Bosch, Antonio
    Broto, Javier Martin
    Comandone, Alessandro
    Cruz, Josefina
    Grignani, Giovanni
    Quagliuolo, Vittorio
    Picci, Piero
    De Paoli, Antonino
    Dei Tos, Angelo Paolo
    Verderio, Paolo
    Casali, Paolo Giovanni
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study
    Dimitrakopoulou-Strauss, Antonia
    Strauss, Ludwig G.
    Egerer, Gerlinde
    Vasamiliette, Julie
    Mechtersheimer, Gunhild
    Schmitt, Thomas
    Lehner, Burkhard
    Haberkorn, Uwe
    Stroebel, Philipp
    Kasper, Bernd
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 551 - 558
  • [28] Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas
    Wendtner, CM
    Abdel-Rahman, S
    Krych, M
    Baumert, J
    Lindner, LH
    Baur, A
    Hiddemann, W
    Issels, RD
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3156 - 3164
  • [29] Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities
    Vanzulli, Andrea
    Vigorito, Raffaella
    Buonomenna, Ciriaco
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Pousa, Antonio Lopez
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Diaz-Beveridge, Robert
    Ferraresi, Virginia
    Lugowska, Iwona A.
    Pizzamiglio, Sara
    Verderio, Paolo
    Duroni, Valeria
    Fontana, Valeria
    Morosi, Carlo
    Stacchiotti, Silvia
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Histology and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS).
    Casali, P. G.
    Stacchiotti, S.
    Verderio, P.
    Collini, P.
    Tos, A. P. Dei
    Alberghini, M.
    Llombart-Bosch, A.
    Morosi, C.
    Messina, A.
    Mercuri, M.
    Gronchi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345